Literature DB >> 1851815

A Gly1 to Ala substitution in poliovirus capsid protein VP0 blocks its myristoylation and prevents viral assembly.

D Marc1, M Girard, S van der Werf.   

Abstract

Capsid protein VP4 of poliovirus is acylated with myristic acid via an amide linkage to its N-terminal glycine residue. Our previous studies suggested that myristic acid plays a role in poliovirus assembly and in the early events of infection. In order to understand better its role in the assembly process, we introduced a Gly1 to Ala amino acid substitution in the myristoylation signal sequence of VP4. This substitution prevented VP0 myristoylation in vivo and abolished the infectivity of genomic transcripts harbouring the mutation. These mutated RNAs were still able to replicate in the transfected cells but the assembly processes were inefficient and no mature virions could be detected.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1851815     DOI: 10.1099/0022-1317-72-5-1151

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  17 in total

Review 1.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  JC virus minor capsid proteins Vp2 and Vp3 are essential for virus propagation.

Authors:  M L Gasparovic; G V Gee; W J Atwood
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

3.  The VP4 peptide of hepatitis A virus ruptures membranes through formation of discrete pores.

Authors:  Ashutosh Shukla; Aditya K Padhi; James Gomes; Manidipa Banerjee
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

4.  Structure, Immunogenicity, and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty Capsid.

Authors:  Xiaoli Wang; Zhiqiang Ku; Xiang Zhang; Xiaohua Ye; Jinhuan Chen; Qingwei Liu; Wei Zhang; Chao Zhang; Zhenglin Fu; Xia Jin; Yao Cong; Zhong Huang
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

5.  Efficient analysis of nonviable poliovirus capsid mutants.

Authors:  J Simons; A Rogove; N Moscufo; C Reynolds; M Chow
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

6.  Antiviral effects of a thiol protease inhibitor on foot-and-mouth disease virus.

Authors:  L G Kleina; M J Grubman
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

7.  Foot-and-mouth disease virus assembly: processing of recombinant capsid precursor by exogenous protease induces self-assembly of pentamers in vitro in a myristoylation-dependent manner.

Authors:  Stewart Goodwin; Tobias J Tuthill; Armando Arias; Richard A Killington; David J Rowlands
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

8.  Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans.

Authors:  D C Ansardi; D C Porter; C D Morrow
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

9.  Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles.

Authors:  D C Ansardi; D C Porter; C D Morrow
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

10.  Characterization of human and rat brain myristoyl-CoA:protein N-myristoyltransferase: evidence for an alternative splice variant of the enzyme.

Authors:  R A McIlhinney; K Young; M Egerton; R Camble; A White; M Soloviev
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.